Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad M Yaqoob

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Circulation|February 10, 2012
Ischemic conditioning protects the uremic heart in a rodent model of myocardial infarctionConor J Byrne, Kieran McCafferty, Julius Kieswich, et al.
Kidney International|July 15, 2005
The selective PPARgamma antagonist GW9662 reverses the protection of LPS in a model of renal ischemia-reperfusionMassimo Collino, Nimesh S A Patel, Kevin M Lawrence, et al.
Kidney International|March 13, 2003
Calpain is activated in experimental uremia: is calpain a mediator of uremia-induced myocardial injury?Steven M Harwood, David A Allen, Alistair M S Chesser, et al.
Journal of the American Society of Nephrology : JASN|December 12, 2018
The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 SignalingPetros Andrikopoulos, Julius Kieswich, Sabrina Pacheco, et al.
Shock (Augusta, Ga.)|June 18, 2004
Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemiaMaha Abdelrahman, Edward J Sharples, Michelle C McDonald, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
Nonresolving inflammation in gp91phox-/- mice, a model of human chronic granulomatous disease, has lower adenosine and cyclic adenosine 5'-monophosphateRavindra Rajakariar, Justine Newson, Edwin K Jackson, et al.
Kidney International|August 26, 2004
Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivoNimesh S A Patel, Edward J Sharples, Salvatore Cuzzocrea, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 17, 2013
The impact of acute kidney injury on midterm outcomes after coronary artery bypass graft surgery: a matched propensity score analysisSean Gallagher, Dan A Jones, Matthew J Lovell, et al.
Frontiers in Immunology|January 9, 2019
Linagliptin Attenuates the Cardiac Dysfunction Associated With Experimental Sepsis in Mice With Pre-existing Type 2 Diabetes by Inhibiting NF-κBSura Al Zoubi, Jianmin Chen, Catherine Murphy, et al.
European Journal of Pharmacology|March 9, 2007
The role of cycloxygenase-2 in the rodent kidney following ischaemia/reperfusion injury in vivoNimesh S A Patel, Salvatore Cuzzocrea, Massimo Collino, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Circulation|February 10, 2012
Ischemic conditioning protects the uremic heart in a rodent model of myocardial infarctionConor J Byrne, Kieran McCafferty, Julius Kieswich, et al.
Kidney International|July 15, 2005
The selective PPARgamma antagonist GW9662 reverses the protection of LPS in a model of renal ischemia-reperfusionMassimo Collino, Nimesh S A Patel, Kevin M Lawrence, et al.
Kidney International|March 13, 2003
Calpain is activated in experimental uremia: is calpain a mediator of uremia-induced myocardial injury?Steven M Harwood, David A Allen, Alistair M S Chesser, et al.
Journal of the American Society of Nephrology : JASN|December 12, 2018
The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 SignalingPetros Andrikopoulos, Julius Kieswich, Sabrina Pacheco, et al.
Shock (Augusta, Ga.)|June 18, 2004
Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemiaMaha Abdelrahman, Edward J Sharples, Michelle C McDonald, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2009
Nonresolving inflammation in gp91phox-/- mice, a model of human chronic granulomatous disease, has lower adenosine and cyclic adenosine 5'-monophosphateRavindra Rajakariar, Justine Newson, Edwin K Jackson, et al.
Kidney International|August 26, 2004
Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivoNimesh S A Patel, Edward J Sharples, Salvatore Cuzzocrea, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 17, 2013
The impact of acute kidney injury on midterm outcomes after coronary artery bypass graft surgery: a matched propensity score analysisSean Gallagher, Dan A Jones, Matthew J Lovell, et al.
Frontiers in Immunology|January 9, 2019
Linagliptin Attenuates the Cardiac Dysfunction Associated With Experimental Sepsis in Mice With Pre-existing Type 2 Diabetes by Inhibiting NF-κBSura Al Zoubi, Jianmin Chen, Catherine Murphy, et al.
European Journal of Pharmacology|March 9, 2007
The role of cycloxygenase-2 in the rodent kidney following ischaemia/reperfusion injury in vivoNimesh S A Patel, Salvatore Cuzzocrea, Massimo Collino, et al.
Pageof 9